NCT05057130 2024-04-01Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone TumorsBlokhin's Russian Cancer Research CenterPhase 2/3 Recruiting50 enrolled